9 July 2015 in Nature Communications
Toxin–antitoxin (TA) systems are implicated in the downregulation of bacterial cell growth associated with stress survival and latent tuberculosis infection, yet the activities and intracellular targets of these TA toxins are largely uncharacterized. Here, we use a specialized RNA-seq approach to identify targets of a Mycobacterium tuberculosis VapC TA toxin, VapC-mt4 (also known as VapC4), which have eluded detection using conventional approaches. Distinct from the one other characterized VapC toxin in M. tuberculosis that cuts 23S rRNA at the sarcin–ricin loop, VapC-mt4 selectively targets three of the 45 M. tuberculosis tRNAs (tRNAAla2, tRNASer26 and tRNASer24) for cleavage at, or adjacent to, their anticodons, resulting in the generation of tRNA halves. While tRNA cleavage is sometimes enlisted as a bacterial host defense mechanism, VapC-mt4 instead alters specific tRNAs to inhibit translation and modulate growth. This stress-linked activity of VapC-mt4 mirrors basic features of eukaryotic tRNases that also generate tRNA halves and inhibit translation in response to stress.
1 September 2016 in Cell Reports
Termination of protein synthesis on the ribosome is catalyzed by release factors (RFs), which share a conserved glycine-glycine-glutamine (GGQ) motif. The glutamine residue is methylated in vivo, but a mechanistic understanding of its contribution to hydrolysis is lacking. Here, we show that the modification, apart from increasing the overall rate of termination on all dipeptides, substantially increases the rate of peptide release on a subset of amino acids. In the presence of unmethylated RFs, we measure rates of hydrolysis that are exceptionally slow on proline and glycine residues and approximately two orders of magnitude faster in the presence of the methylated factors. Structures of 70S ribosomes bound to methylated RF1 and RF2 reveal that the glutamine side-chain methylation packs against 23S rRNA nucleotide 2451, stabilizing the GGQ motif and placing the side-chain amide of the glutamine toward tRNA. These data provide a framework for understanding how release factor modifications impact termination.
1 May 2017 in Journal of Biological Chemistry
Toxin-antitoxin systems are ubiquitous in prokaryotic and archaeal genomes and regulate growth in response to stress. Escherichia coli contains at least 36 putative toxin-antitoxin gene pairs, and some pathogens such as Mycobacterium tuberculosis have over 90 toxin-antitoxin operons. E. coli MazF cleaves free mRNA after encountering stress, and nine M. tuberculosis MazF family members cleave mRNA, tRNA, or rRNA. Moreover, M. tuberculosis MazF-mt6 cleaves 23S rRNA Helix 70 to inhibit protein synthesis. The overall tertiary folds of these MazFs are predicted to be similar, and therefore, it is unclear how they recognize structurally distinct RNAs. Here we report the 2.7-Å X-ray crystal structure of MazF-mt6. MazF-mt6 adopts a PemK-like fold but lacks an elongated β1-β2 linker, a region that typically acts as a gate to direct RNA or antitoxin binding. In the absence of an elongated β1-β2 linker, MazF-mt6 is unable to transition between open and closed states, suggesting that the regulation of RNA or antitoxin selection may be distinct from other canonical MazFs. Additionally, a shortened β1-β2 linker allows for the formation of a deep, solvent-accessible, active-site pocket, which may allow recognition of specific, structured RNAs like Helix 70. Structure-based mutagenesis and bacterial growth assays demonstrate that MazF-mt6 residues Asp-10, Arg-13, and Thr-36 are critical for RNase activity and likely catalyze the proton-relay mechanism for RNA cleavage. These results provide further critical insights into how MazF secondary structural elements adapt to recognize diverse RNA substrates.
1 February 2020 in Biophysical Journal
18 April 2020 in The FASEB Journal
Ribosomal RNA (rRNA) methylation by aminoglycoside‐resistance methyltransferases is presumed to reduce antibiotic activity by sterically occluding part of the drug binding site in helix 44 of 16S rRNA. However, for 4,6‐disubstituted deoxystreptamine (4,6‐DOS) aminoglycosides, the m 1 A1408 aminoglycoside resistance modification results in a wide range of bacterial resistance phenotypes with structurally similar drugs, from complete resistance to highly susceptible. Thus, for currently undefined reasons, some 4,6‐DOS aminoglycosides appear to be able to “evade” the effects of rRNA methylation at A1408. In contrast for the m 7 G1405 aminoglycoside resistance modification, all 4,6‐DOS aminoglycosides are rendered inactive. Why these same drugs are unable to evade this methylation is also currently not mechanistically understood. We will describe the development of a framework for understanding methylated rRNA‐antibiotic interactions through the evaluation of energetics of drug‐methylated rRNA complexes for a collection of 4,6‐DOS aminoglycosides. With computational calculations using Monte Carlo simulations and free energy maps of aminoglycosides, we probed the flexibility around each ring’s dihedral angles (ϕ/ψ) in rRNA bound poses and the contributions of Ring I substituents to drug binding. These analyses revealed three key molecular features that may contribute to evasion of m 1 A1408 modification: 1) The polarity of atoms of the Ring I 6’ substituent; 2) the number of Ring I substituents; and 3) the presence of a L‐hydroxyaminobuteroyl amide (HABA) group on the 2‐DOS core ring. These studies lay a foundation for understanding aminoglycoside‐methylated rRNA interactions at the molecular level and could, for example, directly facilitate design of new aminoglycoside derivatives that retain activity against pathogens harboring aminoglycoside‐resistance rRNA methyltransferases. Support or Funding Information: This work was supported by National Institutes of Health grants R01‐AI088025 (to GLC) and Cystic Fibrosis Foundation postdoctoral fellowship DEY18F0 (to DD).
1 April 2019 in The FASEB Journal
Gene expression relies on the interplay of dozens of proteins and large nucleic acid molecules that assemble into complex macromolecular machines such as the ribosome. These machines are regulated by posttranscriptional and posttranslational modifications. Numerous tRNA modifications, for example, are known to influence the fidelity of mRNA decoding by the ribosome. In the absence of this translational fidelity, nonsense protein products are expressed or premature termination occurs resulting in toxic protein products that overwhelm the cellular proteolysis machinery resulting in cell death. Posttranscriptional modifications of tRNAs have been known for decades but most studies have focused on how anticodon modifications expand the genetic code by allowing non Watson‐Crick base‐pairing at the third position of the codon‐anticodon interaction on the ribosome. However, most tRNAs are also extensively modified outside their anticodon stem‐loop. These modifications affect other aspects of translational fidelity such as the ability of the ribosome to maintain the three‐nucleotide codon of the mRNA as it moves through the ribosome. The absolute requirement for precise correlation between the mRNA frame and the correct protein sequence to be expressed underlies an fundamental question in molecular biology: what regulates the mRNA reading frame? To address this question, we study two examples of defined biological systems that subvert the three‐nucleotide mRNA reading frame resulting in high levels of programmed frameshifting. Our biochemical and structural results reveal that tRNA distortion and conformational changes of the small ribosomal subunit are induced by frameshift‐prone tRNAs and highly structured mRNAs. These programmed gene expression events cause changes in the dynamic motions of the ribosome required for productive translation. This dysregulation causes the ribosome to lose its grip on the mRNA, allowing the tRNA to shift into a new reading frame. Together these studies reveal how the ribosome can be programmed for to encode for alternative mRNA frames and in addition suggest how dysregulation of the mRNA frame may occur by the disruption of key interactions between tRNAs, mRNA, and translation factors with the ribosome. This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .